[The effect of fosamax on bone tissue function in patients with rheumatoid arthritis (based on x-ray densitometry data)].
Data are submitted on results of investigations designed to study mineral density of the osseous tissue in patients with rheumatoid arthritis during therapy with phosamax. Revealed in the study were both a positive clinical effect of the above-named drug and its protective action with respect to systemic resorption of the osseous tissue in patients with rheumatoid arthritis.
Koryl'chuk
N I
NI
Masyk
O M
OM
Bilozets'ka-Smiian
S I
SI
Slaba
U S
US
D015502:Absorptiometry, Photon / Q000706:statistics & numerical data; D000293:Adolescent; D000328:Adult; D019386:Alendronate / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D019386:Alendronate
Vplyv fosamaksu na stan kistkovoï tkanyny u khvorykh na revmatoïdnyĭ artryt (za danymy renthenivs'koï densytometriï).